NATCO PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 524816     NSE : NATCOPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 27,2022
Price(EOD): β‚Ή 679.90
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: β‚Ή 12,414.97 Cr
Value of β‚Ή 1 Lac invested in NATCO PHARMA
on May 29,2017 (price: β‚Ή 888.95)

β‚Ή 1 L

β‚Ή 0.76 L

1W : -3.6% 1M : -13.4% 1Y : -35.8%
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results
NATCO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Industry Peers & Returns1W1M1Y
NATCO PHARMA -3.6% -13.4% -35.8%
SUN PHARMACEUTICAL INDUSTRIES -1.9% -0.2% 29.4%
DIVIS LABORATORIES -9.8% -22.2% -15.5%
DR REDDYS LABORATORIES 2.8% 7.7% -17.4%
CIPLA -0.4% -1.1% 3.1%
GLAND PHARMA -2.5% -7.7% -13%
PIRAMAL ENTERPRISES -12.8% -23.8% 9.1%
CADILA HEALTHCARE 3.1% 8.4% -40.1%
TORRENT PHARMACEUTICALS 12.4% 8.5% 6.5%

FUNDAMENTAL ANALYSIS OF NATCO PHARMA

 
Fundamentals Score
[ Q(TTM): Dec2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights πŸ’‘ NATCOPHARM is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF NATCO PHARMA

 
Valuation Score
[As on : May 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
28.14
P/E Calculated based on EPS of 24.16
[ Mar2021 - Consolidated Results ]

3.02
P/B Calculated based on Book Value of 224.88
[ Mar2021 - Consolidated Results ]

7.39
P/S Calculated based on Revenues of 1679.3 Cr
[ TTM - Consolidated Results ]

Financial Ratios →

Insights πŸ’‘ There are potential 21% undervalued companies ! Discover More →

FAIR VALUE OF NATCO PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
114%
189%
290%

Insights πŸ’‘ You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NATCO PHARMA


Insights πŸ’‘ There are 5% companies with bullish price momentum currently! Discover More →

NATCO PHARMA vs SENSEX


Insights πŸ’‘ You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NATCO PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.06
0.08
0.11
0.08
0.07
0.08
0.11
0.09
[Last Annual Data : Mar2021]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NATCO PHARMA

Pledged Promoter Shares
0 %
As on : Mar2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NATCO PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
48.59%
44.4%
30.37%
23.5%
57.8%
23.39%
13.61%
26.81%
QtrlyTrend
8
Latest Qtr: Dec2021
Quarterly Result Analysis →

Insights πŸ’‘ NATCOPHARM is one of the top 43% companies with good quarterly result uptrend ! Discover More →

NATCO PHARMA related INDICES

BSE Indices1W1M1Y
S&P BSE LARGE MIDCAP 0.2% -6.3% 7.1%
S&P BSE 200 0.2% -6.3% 7.2%
S&P BSE 250 LARGEMIDCAP 0.1% -6.4% 7.2%
S&P BSE MID CAP 0.1% -8.6% 3.9%
S&P BSE 500 -0.1% -6.8% 7.2%
S&P BSE ALLCAP -0.3% -7.1% 7.5%
S&P BSE 150 MIDCAP -0.5% -8% 7.7%
S&P BSE 400 MIDSMALLCAP -1.3% -9.3% 7.2%
S&P BSE MIDSMALLCAP -1.5% -10.1% 7.1%
S&P BSE HEALTHCARE -2% -8.1% -8.7%
NSE Indices1W1M1Y
NIFTY 500 -0.2% -6.9% 7%
NIFTY LARGE MIDCAP 250 -0.3% -7.2% 7.4%
NIFTY500 MULTICAP 50:25:25 -0.8% -8.3% 7.2%
NIFTY MIDCAP150 -0.9% -8.3% 7.8%
NIFTY MID SMALL400 -1.5% -9.7% 7.3%
NIFTY PHARMA -3% -5.8% -9.7%

You may also like the below Video Courses


FAQ about NATCO PHARMA


Is NATCO PHARMA good for long term investment?

As on May 27,2022, the Fundamentals of NATCO PHARMA look Strong and hence it may be good for long term investment! See Financial Performance of NATCO PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NATCO PHARMA UnderValued or OverValued?

As on May 27,2022, NATCO PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NATCO PHARMA ?

As on May 27,2022, the Intrinsic Value of NATCO PHARMA is Rs. 235.29 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 318.10
Fair Value [Median EV / Sales Model] : Rs. 235.29
Fair Value [Median Price / Sales Model] : Rs. 174.19
Median Fair Value of NATCO PHARMA : Rs. 235.29

Is NATCO PHARMA trading at a Premium or Discount?

As on May 27,2022, NATCO PHARMA is trading at a Premium of 189% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z